Results 81 to 90 of about 3,398 (179)

Role of ferric carboxymaltose in the treatment of postpartum anemia in a tertiary care hospital in Andhra Pradesh

, 2021
Background: Postpartum iron deficiency anemia is common in India as a consequence of postpartum hemorrhage.  Recent studies have evaluated the use of parenteral iron as a better tolerated treatment modality.
Krishna, Achint, Krishna, Kirtan, N., Divya Teja G.   +2 more
core   +1 more source

Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations.

PLoS ONE, 2015
BackgroundThere is a significant clinical need for effective treatment of iron deficiency. A number of compounds that can be administered intravenously have been developed.
James R Connor, Xuesheng Zhang, Anne M Nixon, Becky Webb, Joseph R Perno   +4 more
doaj   +1 more source

Iron Deficiency in Heart Failure: Cellular Mechanisms and Therapeutic Implications

Journal of Cardiovascular Development and Disease
Iron deficiency (ID) is a prevalent comorbidity in heart failure (HF), affecting 37–75% of patients and contributing significantly to symptom burden and adverse outcomes independent of anemia status.
Anastasios Tsarouchas, Vassilios P. Vassilikos, Dimitrios Mouselimis, Christodoulos E. Papadopoulos, Dimitrios Tachmatzidis, Aikaterini Vassilikou, Constantinos Bakogiannis   +6 more
doaj   +1 more source

A Comparative Study of IV Ferric Carboxymaltose Versus Iron Sucrose in Treatment of Iron Deficiency Anemia in Pregnancy

, 2023
Background: To compare Intravenous Iron Sucrose Compound (ISC) with intravenous Ferric Carboxymaltose (FCM) in terms of efficacy as well as safety for treating iron deficient anaemia in pregnant patients.
Keya Patel, Archana Rokade, Ashish Kalburgi
core  

A study for efficacy and safety of ferric carboxymaltose versus iron sucrose in iron deficiency anemia among pregnant women in tertiary care hospital

, 2019
Background: Anemia is one of the common manageable problem among the pregnant women worldwide, which contributes to maternal and perinatal mortality. This study aims to compare the efficacy and safety of intravenous ferric carboxymaltose with intravenous
Agrawal, Divyani, Masand, Deepa Lokwani
core   +1 more source

Novel Therapies to Reduce Rehospitalization Risk in Worsening Heart Failure

JACC: Advances
Background: Worsening heart failure (WHF) challenges health care with frequent rehospitalizations and reduced quality of life for patients. Despite therapeutic advances, high rehospitalization risks highlight the urgent need for new treatments ...
Ivna G.C.V. Lima, MD, Jairo T. Nunes, MD, Lucas C. Godoy, MD PhD, Michael McDonald, MD, Edimar A. Bocchi, MD, PhD   +4 more
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Porphyria Cutanea Tarda in a Patient with End-Stage Renal Disease: A Case of Successful Treatment with Deferoxamine and Ferric Carboxymaltose

Case Reports in Nephrology, 2017
Porphyria cutanea tarda (PCT) is a rare disease, with a strong association with hepatitis C virus. PCT is particularly problematic in end-stage renal disease patients as they have no renal excretion of porphyrins and these are poorly dialyzed.
Natacha Rodrigues, Fernando Caeiro, Alice Santana, Teresa Mendes, Leonor Lopes   +4 more
doaj   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Hypocalcemia and Hypophosphatemia following Concurrent Denosumab Injection and Ferric Carboxymaltose Infusion in a Patient with Normal Renal Function

Case Reports in Endocrinology
Hypocalcemia following denosumab administration is well described. Hypophosphatemia following an intravenous iron infusion is an increasingly recognized adverse effect.
Naomi Szwarcbard, Chloe Dawson, Lai-Ming Kathleen Pak, Kathryn L. Hackman   +3 more
doaj   +1 more source